Chapter 1. Introduction

  1. Peter M. Fayers1,2 and
  2. David Machin3,4,5

Published Online: 27 APR 2007

DOI: 10.1002/9780470024522.ch1

Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, Second edition

Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, Second edition

How to Cite

Fayers, P. M. and Machin, D. (2007) Introduction, in Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, Second edition, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470024522.ch1

Author Information

  1. 1

    University of Aberdeen Medical School, Scotland, UK

  2. 2

    Norwegian University of Science and Technology (NTNU), Trondheim, Norway

  3. 3

    Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore

  4. 4

    School of Health and Related Research, University of Sheffield, England

  5. 5

    United Kingdom Children's Cancer Study Group (UKCCSG), University of Leicester, England

Publication History

  1. Published Online: 27 APR 2007
  2. Published Print: 2 MAR 2007

ISBN Information

Print ISBN: 9780470024508

Online ISBN: 9780470024522

SEARCH

Keywords:

  • randomised controlled trial (RCT);
  • health-related quality of life (HRQoL or HRQL);
  • Quality of life (QoL);
  • LASA approach or visual analogue scale (VAS);
  • QoL instruments;
  • measuring quality of life;
  • Schedule for Evaluation of Individual Quality of Life (SEIQoL);
  • Patient Generated Index (PGI);
  • disease-specific questionnaires

Summary

This chapter contains sections titled:

  • Patient-reported outcomes

  • What is quality of life?

  • Historical development

  • Why measure quality of life?

  • Which clinical trials should assess quality of life?

  • How to measure quality of life

  • Instruments

  • Conclusions